Jacob Tveiten Bjerrum

1.7k total citations
45 papers, 1.2k citations indexed

About

Jacob Tveiten Bjerrum is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Jacob Tveiten Bjerrum has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 26 papers in Epidemiology and 13 papers in Molecular Biology. Recurrent topics in Jacob Tveiten Bjerrum's work include Inflammatory Bowel Disease (26 papers), Microscopic Colitis (17 papers) and Gut microbiota and health (9 papers). Jacob Tveiten Bjerrum is often cited by papers focused on Inflammatory Bowel Disease (26 papers), Microscopic Colitis (17 papers) and Gut microbiota and health (9 papers). Jacob Tveiten Bjerrum collaborates with scholars based in Denmark, China and United Kingdom. Jacob Tveiten Bjerrum's co-authors include Ole Haagen Nielsen, Jørgen Olsen, Yulan Wang, Jakob Benedict Seidelin, Fuhua Hao, Mehmet Coskun, Ulrich L. Günther, Christian Ludwig, Christoffer Soendergaard and Cláudio Csillag and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Jacob Tveiten Bjerrum

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Tveiten Bjerrum Denmark 19 561 459 276 256 237 45 1.2k
Amosy E. M’Koma United States 19 260 0.5× 521 1.1× 356 1.3× 157 0.6× 266 1.1× 43 1.0k
Katarzyna Neubauer Poland 21 260 0.5× 341 0.7× 219 0.8× 221 0.9× 196 0.8× 50 975
Serge Dionne Canada 17 285 0.5× 351 0.8× 252 0.9× 244 1.0× 143 0.6× 28 1.1k
Monia Baldoni Italy 18 241 0.4× 173 0.4× 295 1.1× 184 0.7× 214 0.9× 30 1.0k
Elisabetta Cavalcanti Italy 20 425 0.8× 146 0.3× 192 0.7× 181 0.7× 110 0.5× 39 1.0k
Bernd Sido Germany 17 250 0.4× 195 0.4× 205 0.7× 307 1.2× 233 1.0× 43 1.2k
Dario Sorrentino Italy 23 449 0.8× 460 1.0× 517 1.9× 146 0.6× 499 2.1× 62 1.7k
Martin Leníček Czechia 20 490 0.9× 183 0.4× 366 1.3× 80 0.3× 334 1.4× 65 1.2k
Myunghee Hong South Korea 16 210 0.4× 389 0.8× 218 0.8× 167 0.7× 200 0.8× 38 991
Shoichi Kado Japan 13 470 0.8× 166 0.4× 155 0.6× 111 0.4× 104 0.4× 25 889

Countries citing papers authored by Jacob Tveiten Bjerrum

Since Specialization
Citations

This map shows the geographic impact of Jacob Tveiten Bjerrum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Tveiten Bjerrum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Tveiten Bjerrum more than expected).

Fields of papers citing papers by Jacob Tveiten Bjerrum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Tveiten Bjerrum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Tveiten Bjerrum. The network helps show where Jacob Tveiten Bjerrum may publish in the future.

Co-authorship network of co-authors of Jacob Tveiten Bjerrum

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Tveiten Bjerrum. A scholar is included among the top collaborators of Jacob Tveiten Bjerrum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Tveiten Bjerrum. Jacob Tveiten Bjerrum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Attauabi, Mohamed, Klaus Theede, Jacob Tveiten Bjerrum, et al.. (2025). Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohn’s Disease: A Copenhagen IBD Cohort Study. Clinical Gastroenterology and Hepatology. 23(8). 1398–1407.e6. 2 indexed citations
2.
Wilkens, Rune, Mohamed Attauabi, Klaus Theede, et al.. (2025). Intestinal ultrasound as a prognostic tool in new-onset ulcerative colitis—a Copenhagen IBD Cohort Study. Journal of Crohn s and Colitis. 19(4). 2 indexed citations
3.
Seidelin, Jakob Benedict, Mohamed Attauabi, Anders Woetmann, et al.. (2024). Non-TGFβ profibrotic signaling in ulcerative colitis after in vivo experimental intestinal injury in humans. American Journal of Physiology-Gastrointestinal and Liver Physiology. 327(1). G70–G79. 3 indexed citations
4.
Attauabi, Mohamed, Flemming Bendtsen, Jacob Tveiten Bjerrum, et al.. (2023). P293 Correlation between clinical measures to capture disease burden and prediction of the initial course of Crohn’s disease - findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study). Journal of Crohn s and Colitis. 17(Supplement_1). i437–i440.
5.
Attauabi, Mohamed, Flemming Bendtsen, Christian Jakobsen, et al.. (2023). DOP19 Incidence and initial disease presentation of inflammatory bowel diseases in Denmark: findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study). Journal of Crohn s and Colitis. 17(Supplement_1). i82–i85.
6.
Bjerrum, Jacob Tveiten, et al.. (2023). Rectal Cancer Risk After Colectomy in Patients With Inflammatory Bowel Disease—A Population-Based Danish Cohort Study 1978–2018. SHILAP Revista de lepidopterología. 2(6). 853–859. 1 indexed citations
7.
Johansen, Jens Vilstrup, et al.. (2023). P032 Distinct immune cell trigger responses in Ulcerative Colitis – Results from an in vivo human intestinal injury model. Journal of Crohn s and Colitis. 17(Supplement_1). i199–i200.
8.
Attauabi, Mohamed, Flemming Bendtsen, Rune Wilkens, et al.. (2022). P238 Symptom burden and indolent disease in newly diagnosed patients with ulcerative colitis and Crohn’s disease - a Copenhagen IBD Inception Cohort Study. Journal of Crohn s and Colitis. 16(Supplement_1). i285–i287. 1 indexed citations
9.
Bjerrum, Jacob Tveiten, Yulan Wang, Jingtao Zhang, et al.. (2022). Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets. International Journal of Biological Sciences. 18(5). 1813–1828. 8 indexed citations
10.
Nielsen, Ole Haagen, Søren Jacobsen, Lene Riis, et al.. (2021). 1685P COLAR: Results from an intervention study investigating IL-6 blockade with tocilizumab for treatment of immune checkpoint inhibitor induced colitis and arthritis. Annals of Oncology. 32. S1180–S1180. 1 indexed citations
11.
Seidelin, Jakob Benedict, Martin Iain Bahl, Tine Rask Licht, et al.. (2021). Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans. Cellular and Molecular Gastroenterology and Hepatology. 12(4). 1281–1296. 11 indexed citations
12.
Soendergaard, Christoffer, et al.. (2018). Targeting JAK-STAT signal transduction in IBD. Pharmacology & Therapeutics. 192. 100–111. 79 indexed citations
13.
Bjerrum, Jacob Tveiten, Casper Steenholdt, Mark Ainsworth, et al.. (2017). Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease. BMC Medicine. 15(1). 184–184. 41 indexed citations
14.
Bjerrum, Jacob Tveiten, Yulan Wang, Fuhua Hao, et al.. (2014). Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals. Metabolomics. 11(1). 122–133. 201 indexed citations
15.
Bjerrum, Jacob Tveiten, Ole Haagen Nielsen, Lene Riis, et al.. (2014). Transcriptional Analysis of Left-sided Colitis, Pancolitis, and Ulcerative Colitis-associated Dysplasia. Inflammatory Bowel Diseases. 20(12). 2340–2352. 31 indexed citations
16.
Bjerrum, Jacob Tveiten, Mattias Rantalainen, Yulan Wang, Jørgen Olsen, & Ole Haagen Nielsen. (2013). Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis. Metabolomics. 10(2). 280–290. 23 indexed citations
17.
Nielsen, Ole Haagen, Jacob Tveiten Bjerrum, Hans Herfarth, & Gerhard Rogler. (2013). Recent Advances Using Immunomodulators for Inflammatory Bowel Disease. The Journal of Clinical Pharmacology. 53(6). 575–588. 40 indexed citations
18.
Nielsen, Ole Haagen, et al.. (2012). Biological Treatment of Crohn’s Disease. Digestive Diseases. 30(Suppl. 3). 121–133. 8 indexed citations
19.
Langholz, Ebbe, et al.. (2010). [Development of colorectal cancer in ulcerative colitis].. PubMed. 172(43). 2960–2. 3 indexed citations
20.
Olsen, Jørgen, Thomas Alexander Gerds, Jakob Benedict Seidelin, et al.. (2009). Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome-wide gene expression data. Inflammatory Bowel Diseases. 15(7). 1032–1038. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026